[HTML][HTML] The risk of QTc-interval prolongation in breast cancer patients treated with tamoxifen in combination with serotonin reuptake inhibitors

KGAM Hussaarts, FA Berger, L Binkhorst… - Pharmaceutical …, 2020 - Springer
Purpose Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

[HTML][HTML] The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

KGAM Hussaarts, FA Berger, L Binkhorst… - Pharmaceutical …, 2020 - ncbi.nlm.nih.gov
Purpose Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

KGAM Hussaarts, FA Berger… - Pharmaceutical …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

K Hussaarts, F Berger, L Binkhorst… - Pharmaceutical …, 2020 - repub.eur.nl
Purpose: Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

KGAM Hussaarts, FA Berger, L Binkhorst… - Pharmaceutical …, 2020 - search.proquest.com
Purpose Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

[PDF][PDF] THE RISK OF QTC-INTERVAL PROLONGATION IN BREAST CANCER PATIENTS TREATED WITH TAMOXIFEN IN COMBINATION WITH SEROTONIN …

KGAM Hussaarts, FA Berger, L Binkhorst… - … WITH ANTI-CANCER …, 2020 - core.ac.uk
Purpose. Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.

KGAM Hussaarts, FA Berger… - Pharmaceutical …, 2020 - search.ebscohost.com
Purpose: Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.

K Hussaarts, FA Berger, L Binkhorst… - Pharmaceutical …, 2019 - europepmc.org
Purpose Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

[PDF][PDF] THE RISK OF QTC-INTERVAL PROLONGATION IN BREAST CANCER PATIENTS TREATED WITH TAMOXIFEN IN COMBINATION WITH SEROTONIN …

KGAM Hussaarts, FA Berger, L Binkhorst… - … WITH ANTI-CANCER …, 2020 - repub.eur.nl
Purpose. Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …

[PDF][PDF] The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

KGAM Hussaarts, FA Berger, L Binkhorst, E Oomen-de… - Pharm Res, 2020 - core.ac.uk
Purpose Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …